• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Deprescribing in Palliative Cancer Care.姑息性癌症护理中的减药
Life (Basel). 2022 Apr 20;12(5):613. doi: 10.3390/life12050613.
2
3
Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.目标性药物精简在门诊血液透析单元中的应用:减少多种药物治疗的质量改进研究。
Am J Kidney Dis. 2017 Nov;70(5):611-618. doi: 10.1053/j.ajkd.2017.02.374. Epub 2017 Apr 14.
4
Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis.停用双重用途药物对临终老年人患者相关结局的影响:一项系统评价和荟萃分析。
Ther Adv Drug Saf. 2021 Oct 22;12:20420986211052343. doi: 10.1177/20420986211052343. eCollection 2021.
5
Deprescribing as a Clinical Improvement Focus.减少药物作为临床改善重点。
J Am Med Dir Assoc. 2020 Mar;21(3):355-360. doi: 10.1016/j.jamda.2019.08.031. Epub 2019 Oct 28.
6
Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home.对即将出院至养老院的老年内科住院患者进行非特异性减药的前瞻性队列研究。
Ther Adv Drug Saf. 2021 Oct 22;12:20420986211052344. doi: 10.1177/20420986211052344. eCollection 2021.
7
Deprescribing Statins and Proton Pump Inhibitors in Nursing Home Residents; a Pragmatic Exploratory Study.疗养院居民停用他汀类药物和质子泵抑制剂的实用探索性研究。
Gerontol Geriatr Med. 2021 Oct 24;7:23337214211050807. doi: 10.1177/23337214211050807. eCollection 2021 Jan-Dec.
8
Consultation-Based Deprescribing Service to Optimize Palliative Care for Terminal Cancer Patients.基于会诊的减药服务以优化晚期癌症患者的姑息治疗
J Clin Med. 2023 Nov 30;12(23):7431. doi: 10.3390/jcm12237431.
9
Deprescription in Advanced Cancer Patients Referred to Palliative Care.晚期癌症患者转诊至姑息治疗时的减药处理
J Pain Palliat Care Pharmacother. 2016 Sep;30(3):201-5. doi: 10.1080/15360288.2016.1204411. Epub 2016 Aug 5.
10
Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.澳大利亚老年人对多重用药、他汀类药物使用以及减少他汀类药物处方的意愿的态度。
Int J Clin Pharm. 2015 Oct;37(5):949-57. doi: 10.1007/s11096-015-0147-7. Epub 2015 Jun 6.

引用本文的文献

1
Late Deprescribing of Angiotensin-Converting-Enzyme Inhibitors and Renin-Angiotensin Blockers in Patients with Advanced Cancer Receiving Palliative Care.晚期癌症姑息治疗患者中血管紧张素转换酶抑制剂和肾素-血管紧张素阻滞剂的延迟撤药
Palliat Med Rep. 2025 Aug 28;6(1):403-407. doi: 10.1177/26892820251372015. eCollection 2025.
2
Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis.共同决策与减药以支持处于生命终末期的癌症患者抗血栓治疗的(停)用:一项实在论综合分析
PLoS Med. 2025 Aug 25;22(8):e1004663. doi: 10.1371/journal.pmed.1004663. eCollection 2025 Aug.
3
A qualitative study on ICU nurses' perceptions of palliative care.一项关于重症监护室护士对姑息治疗看法的定性研究。
BMC Nurs. 2025 May 13;24(1):521. doi: 10.1186/s12912-025-03164-z.
4
Prescribing and deprescribing in older people with life-limiting illnesses receiving hospice care at the end of life: A longitudinal, retrospective cohort study.在生命末期接受临终关怀的患有绝症的老年人中开具和停用处方:一项纵向、回顾性队列研究。
Palliat Med. 2024 Jan;38(1):121-130. doi: 10.1177/02692163231209024. Epub 2023 Nov 30.
5
Deprescription in Palliative Care.姑息治疗中的减药
Cureus. 2023 May 27;15(5):e39578. doi: 10.7759/cureus.39578. eCollection 2023 May.
6
Perspectives on deprescribing in palliative care.舒缓治疗中药物减量的观点。
Expert Rev Clin Pharmacol. 2023 May;16(5):411-421. doi: 10.1080/17512433.2023.2197592. Epub 2023 Apr 19.
7
Anticoagulant use and associated outcomes in older patients receiving home palliative care: a retrospective cohort study.在接受家庭姑息治疗的老年患者中使用抗凝剂和相关结局:一项回顾性队列研究。
CMAJ. 2022 Sep 12;194(35):E1198-E1208. doi: 10.1503/cmaj.220919.

本文引用的文献

1
Sex Differences in the Effect of Vitamin D on Fatigue in Palliative Cancer Care-A Post Hoc Analysis of the Randomized, Controlled Trial 'Palliative-D'.维生素D对姑息性癌症护理中疲劳影响的性别差异——随机对照试验“Palliative-D”的事后分析
Cancers (Basel). 2022 Jan 31;14(3):746. doi: 10.3390/cancers14030746.
2
Crosstalk between Statins and Cancer Prevention and Therapy: An Update.他汀类药物与癌症预防和治疗之间的相互作用:最新进展
Pharmaceuticals (Basel). 2021 Nov 25;14(12):1220. doi: 10.3390/ph14121220.
3
Potentially Inappropriate Prescribing for Prostatic Hyperplasia in Older Persons.老年人前列腺增生的潜在不适当处方。
J Am Med Dir Assoc. 2022 Jun;23(6):992-997. doi: 10.1016/j.jamda.2021.09.023. Epub 2021 Oct 13.
4
Discontinuation of bisphosphonates in seniors: a systematic review on health outcomes.老年人停用双膦酸盐:对健康结局的系统评价。
Arch Osteoporos. 2021 Sep 15;16(1):133. doi: 10.1007/s11657-021-01000-w.
5
To Deprescribe or Not to Deprescribe Aspirin-A Clear Indication Is the Challenge.停用还是不停用阿司匹林——明确的指征是个挑战。
JAMA Intern Med. 2021 Nov 1;181(11):1540-1541. doi: 10.1001/jamainternmed.2021.4590.
6
'Palliative-D'-Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial.对姑息治疗的癌症患者补充“姑息-D”维生素D:一项双盲、随机、安慰剂对照的多中心试验。
Cancers (Basel). 2021 Jul 23;13(15):3707. doi: 10.3390/cancers13153707.
7
Anticoagulation for patients with mechanical heart valves at the end of life: understanding clinician attitudes and improving decision making.终末期机械心脏瓣膜患者的抗凝治疗:了解临床医生的态度并改善决策。
BMC Palliat Care. 2021 Jul 16;20(1):113. doi: 10.1186/s12904-021-00809-z.
8
Anticoagulant Use for Atrial Fibrillation Among Persons With Advanced Dementia at the End of Life.终末期老年痴呆患者的房颤抗凝治疗。
JAMA Intern Med. 2021 Aug 1;181(8):1121-1123. doi: 10.1001/jamainternmed.2021.1819.
9
Sex-Differences in Discontinuation of Statin Treatment in Cancer Patients the Year before Death.癌症患者死亡前一年他汀类药物治疗停药情况的性别差异。
Pharmaceuticals (Basel). 2021 Apr 16;14(4):368. doi: 10.3390/ph14040368.
10
Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication.无明确适应证时加用阿司匹林与直接口服抗凝剂治疗相关的不良事件。
JAMA Intern Med. 2021 Jun 1;181(6):817-824. doi: 10.1001/jamainternmed.2021.1197.

姑息性癌症护理中的减药

Deprescribing in Palliative Cancer Care.

作者信息

Hedman Christel, Frisk Gabriella, Björkhem-Bergman Linda

机构信息

Department of Molecular Medicine and Surgery, Karolinska Institutet, Anna Steckséns Gata 53, SE-171 76 Stockholm, Sweden.

R & D Department, Stockholms Sjukhem Foundation, Mariebergsgatan 22, SE-112 19 Stockholm, Sweden.

出版信息

Life (Basel). 2022 Apr 20;12(5):613. doi: 10.3390/life12050613.

DOI:10.3390/life12050613
PMID:35629281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9147815/
Abstract

The aim of palliative care is to maintain as high a quality of life (QoL) as possible despite a life-threatening illness. Thus, the prescribed medications need to be evaluated and the benefit of each treatment must be weighed against potential side effects. Medications that contribute to symptom relief and maintained QoL should be prioritized. However, studies have shown that treatment with preventive drugs that may not benefit the patient in end-of-life is generally deprescribed very late in the disease trajectory of cancer patients. Yet, knowing how and when to deprescribe drugs can be difficult. In addition, some drugs, such as beta-blockers, proton pump inhibitors, anti-depressants and cortisone need to be scaled down slowly to avoid troublesome withdrawal symptoms. In contrast, other medicines, such as statins, antihypertensives and vitamins, can be discontinued directly. The aim of this review is to give some advice according to when and how to deprescribe medications in palliative cancer care according to current evidence and clinical praxis. The review includes antihypertensive drugs, statins, anti-coagulants, aspirin, anti-diabetics, proton pump inhibitors, histamin-2-blockers, bisphosphonates denosumab, urologicals, anti-depressants, cortisone, thyroxin and vitamins.

摘要

姑息治疗的目的是尽管患有危及生命的疾病,但仍要尽可能维持较高的生活质量(QoL)。因此,需要对所开药物进行评估,并且必须权衡每种治疗的益处与潜在的副作用。应优先考虑有助于缓解症状和维持生活质量的药物。然而,研究表明,对于临终患者可能无益处的预防性药物,在癌症患者的疾病进程中通常很晚才停止使用。然而,了解如何以及何时停用药物可能很困难。此外,一些药物,如β受体阻滞剂、质子泵抑制剂、抗抑郁药和皮质醇,需要缓慢减量以避免出现麻烦的戒断症状。相比之下,其他药物,如他汀类药物、抗高血压药和维生素,可以直接停用。本综述的目的是根据当前证据和临床实践,就姑息性癌症护理中何时以及如何停用药物提供一些建议。该综述包括抗高血压药物、他汀类药物、抗凝剂、阿司匹林、抗糖尿病药物、质子泵抑制剂、组胺-2受体阻滞剂、双膦酸盐、地诺单抗、泌尿系统药物、抗抑郁药、皮质醇、甲状腺素和维生素。